XT
BRTX icon

XTX Topco’s BioRestorative Therapies BRTX Stock Holding History

XTX Topco’s Portfolio BRTX Stock Details BRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$108K Buy
+286,504
New +$83.8K ﹤0.01% 3509

Other funds holding BRTX

Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
WA
Wealth Alliance Mellville, New York $1.2B AUM 26.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KFGK
Keystone Financial Group (Kentucky) Lexington, Kentucky $1.69B AUM 40.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

XTX Topco's BRTX Position: Q2 2026 in Review

XTX Topco opened a new position in BioRestorative Therapies (BRTX) in Q2 2026: 286,504 shares worth $108K. The stake represents ﹤0.01% of the portfolio and ranks #3509 among its holdings.

21 funds tracked by Wall St. Rank hold BRTX as of Q2 2026.

  • XTX Topco held 286,504 shares of BioRestorative Therapies worth $108K as of Q2 2026.
  • BioRestorative Therapies was a new XTX Topco position in Q2 2026.
  • BioRestorative Therapies made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3509 holding.
  • 21 funds tracked by Wall St. Rank held BioRestorative Therapies as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.